Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tango Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +46 vs. Q2 2021
- Shares held
- 65.5M
- +65.5M vs. Q2 2021
- Total value
- $844.9M
- +$844.9M vs. Q2 2021
- New holders
- 46
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 30 | $0 | 0.00% | +30 | New |
| Wells Fargo & Company | 391 | $5.00K | 0.00% | +391 | New |
| Tower Research Capital LLC (TRC) | 828 | $11.0K | 0.00% | +828 | New |
| JPMorgan Chase & Co | 1,812 | $23.0K | 0.00% | +1,812 | New |
| Morgan Stanley | 1,847 | $24.0K | 0.00% | +1,847 | New |
| Citigroup Inc | 3,169 | $41.0K | 0.00% | +3,169 | New |
| Penserra Capital Management LLC | 10,344 | $133.0K | 0.00% | +10,344 | New |
| Victory Capital Management Inc | 11,022 | $143.0K | 0.00% | +11,022 | New |
| Old Well Partners, LLC | 11,554 | $149.0K | 0.08% | +11,554 | New |
| Walleye Trading LLC | 13,805 | $178.0K | 0.00% | +13,805 | New |
| Cubist Systematic Strategies, LLC | 15,792 | $204.0K | 0.00% | +15,792 | New |
| Charles Schwab Investment Management Inc | 24,311 | $315.0K | 0.00% | +24,311 | New |
| Bank of New York Mellon Corp | 25,221 | $326.0K | 0.00% | +25,221 | New |
| Aviva Holdings Ltd. | 26,961 | $349.0K | 0.05% | +26,961 | New |
| Janney Montgomery Scott LLC | 40,000 | $517.0K | 0.00% | +40,000 | New |
| Walleye Capital LLC | 41,415 | $535.0K | 0.02% | +41,415 | New |
| Affinity Asset Advisors, LLC | 50,000 | $647.0K | 0.26% | +50,000 | New |
| Ensign Peak Advisors, Inc | 53,500 | $692.0K | 0.00% | +53,500 | New |
| Pura Vida Investments, LLC | 84,762 | $1.10M | 0.08% | +84,762 | New |
| Nantahala Capital Management, LLC | 100,000 | $1.29M | 0.08% | +100,000 | New |
| Northern Trust Corp | 113,150 | $1.46M | 0.00% | +113,150 | New |
| State Street Corp | 198,100 | $2.56M | 0.00% | +198,100 | New |
| Farallon Capital Management, L.L.C. | 300,000 | $3.88M | 0.02% | +300,000 | New |
| Avidity Partners Management LP | 300,000 | $3.88M | 0.10% | +300,000 | New |
| Citadel Advisors LLC | 408,525 | $5.28M | 0.01% | +408,525 | New |
| Alyeska Investment Group, L.P. | 424,638 | $5.49M | 0.07% | +424,638 | New |
| Geode Capital Management, LLC | 428,635 | $5.54M | 0.00% | +428,635 | New |
| Tang Capital Management LLC | 468,750 | $6.06M | 1.26% | +468,750 | New |
| Woodline Partners LP | 500,040 | $6.47M | 0.11% | +500,040 | New |
| RTW Investments, LP | 600,000 | $7.76M | 0.12% | +600,000 | New |
| Samsara BioCapital, LLC | 700,000 | $9.05M | 1.50% | +700,000 | New |
| Harvard Management Co Inc | 708,385 | $9.16M | 0.54% | +708,385 | New |
| Baker Bros. Advisors LP | 750,000 | $9.70M | 0.04% | +750,000 | New |
| EcoR1 Capital, LLC | 1,300,000 | $16.8M | 0.59% | +1,300,000 | New |
| Vanguard Group Inc | 1,384,826 | $17.9M | 0.00% | +1,384,826 | New |
| BlackRock Inc. | 1,393,168 | $18.0M | 0.00% | +1,393,168 | New |
| Avoro Capital Advisors LLC | 1,550,000 | $20.0M | 0.32% | +1,550,000 | New |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $24.8M | 1.54% | +1,921,790 | New |
| Ra Capital Management, L.P. | 2,250,000 | $29.1M | 0.40% | +2,250,000 | New |
| Southpoint Capital Advisors LP | 3,000,000 | $38.8M | 0.83% | +3,000,000 | New |
| Cormorant Asset Management, LP | 3,899,185 | $48.8M | 1.98% | +3,899,185 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 4,373,982 | $56.6M | 0.74% | +4,373,982 | New |
| Casdin Capital, LLC | 5,487,910 | $71.0M | 1.77% | +5,487,910 | New |
| FMR LLC | 6,251,913 | $80.8M | 0.01% | +6,251,913 | New |
| Boxer Capital, LLC | 6,871,642 | $88.8M | 3.10% | +6,871,642 | New |
| TRV GP IV, LLC | 19,363,975 | $250.4M | 56.81% | +19,363,975 | New |